Gujarat Alkalies & Chemicals Ltd
GUJALKALI NSE
Gujarat Alkalies & Chemicals Ltd
ChemicalsNSE: GUJALKALI BSE: 530001 Commodity Chemicals
Key Fundamentals
MicrocapCommodity ChemicalsChemicalsMarket Cap
₹4,975 Cr
Volatility
Moderate
P/E Ratio
75.06
EBITDA
₹382 Cr
Return on Equity
-1.15%
Debt to Equity
0.11
Book Value
₹706.82
EPS
₹0
52W High
₹815
52W Low
₹409.15
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Gujarat Alkalies & Chemicals Ltd insights
37 extracted metrics + investor summaries across FY12–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Stock is trading at 0.96 times its book value
Weaknesses
1- Company has a low return on equity of -1.75% over last 3 years.
Growth Rate
Revenue Growth
4.64% ↘
Net Income Growth
-130.25% ↘
Cash Flow Change
472.17% ↗
ROE
-70.51% ↘
ROCE
-91.76% ↘
EBITDA Margin (Avg.)
-21.44% ↘
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 43d agoAI opinion · based on fundamentals
Risk high
Gujarat Alkalies & Chemicals Ltd (GACL) is a state-promoted commodity chemicals company trading at a market cap of ₹4,450 Cr with a price-to-book of 0.86x, reflecting depressed profitability — the company posted a negative PE of -1846x and a 3-year average ROE of -2%. While FY25 revenue grew 7% YoY to ₹4,073 Cr and net profit turned marginally positive at ₹15.8 Cr (vs a loss of ₹132 Cr in FY24), the recovery remains nascent against a backdrop of heavy capex commitments and weak interest coverage.
Bull Case 8
- Stock trades at 0.86x book value, offering a margin of safety for a Gujarat Government-promoted company with significant fixed assets
- FY25 revenue grew 7% YoY to ₹4,073 Cr, reversing a 3-year compounded sales decline of -1% and indicating demand stabilisation
- Net profit swung from a loss of ₹132 Cr in FY24 to a profit of ₹15.8 Cr in FY25, a turnaround reflected in TTM profit growth of 96%
- Promoter holding increased by 1.00% in the latest quarter, signalling state-government confidence in the business outlook
- Dividend yield of 2.59% provides income support even during a weak earnings cycle
- Board approved ₹1,029 Cr in expansion projects including biofuel/coal boilers at Vadodara and Dahej, plus a new 700 MTPD Caustic Evaporation Unit — one of India's largest — positioning for volume-led recovery
- Expansion into value-added products (High Purity Hydrogen Peroxide, ₹81 Cr investment in 3 new downstream plants) signals a strategic shift up the value chain from pure commodity chemicals
- Renewable energy buildout of 177.6 MW (62.7 MW + 72 MW + 42.9 MW hybrid) under captive SPV should reduce long-term power costs, which stood at ₹1,219 Cr in FY25
Bear Case 8
- Negative PE ratio of -1846x reflects near-zero profitability; FY25 net profit of ₹15.8 Cr on revenue of ₹4,073 Cr implies a net margin of just 0.4%
- 3-year average ROE of -2% and last-year ROE of approximately 0% indicate the company is barely earning its cost of equity
- Low interest coverage ratio with interest costs rising from ₹44.6 Cr in FY24 to ₹50.5 Cr in FY25, while operating profit was only ₹360 Cr before depreciation of ₹392 Cr
- Depreciation of ₹392 Cr in FY25 nearly matches EBITDA of ₹452 Cr, leaving minimal free cash flow for debt reduction
- Power and fuel costs of ₹1,219 Cr in FY25 (30% of revenue) expose the company to energy price volatility in a commodity business
- 5-year compounded profit growth is negligible (not meaningfully calculable) given the FY24 loss of ₹132 Cr and thin FY25 profit, indicating structural margin fragility
- Stock has delivered a 3-year CAGR of -3%, underperforming both broader indices and chemical sector peers during the same period
- Large capex commitments (₹1,029 Cr expansion approved) risk further balance sheet stress if caustic soda pricing remains weak, given already low interest coverage
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 43d ago Positives 1
- ₹32Cr renewable energy investment Jun 11
GACL invested ₹32.33 Cr to maintain its 26% stake in Cleanmax Sphere Energy for a 75.9 MW renewable energy project, signaling commitment to green energy and potential long-term cost savings.
Neutral 1
- No share encumbrance confirmed Jun 16
Gujarat Maritime Board confirmed it did not encumber any shares in Gujarat Alkalies & Chemicals during FY 2025-26, indicating clean shareholding structure.
TL;DR: Limited news flow for GACL in recent weeks. The company is making steady progress on its renewable energy strategy through its Cleanmax stake, while corporate governance remains clean with no share encumbrance issues. With no material headwinds reported, the near-term outlook appears stable but lacks strong catalysts.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 913 | 971 | 921 | 1,002 | 977 | 991 | 1,029 | 1,075 | 1,105 | 1,083 | 1,044 | 1,125 | 1,245 |
| Expenses | 882 | 955 | 941 | 998 | 923 | 945 | 951 | 974 | 1,010 | 1,009 | 948 | 1,015 | 1,023 |
| Operating Profit | 31 | 16 | -20 | 4 | 54 | 46 | 78 | 101 | 95 | 74 | 96 | 110 | 222 |
| OPM % | 3.4% | 1.7% | -2.2% | 0.4% | 6% | 4.7% | 8% | 9% | 9% | 7% | 9% | 10% | 18% |
| Other Income | 12 | 71 | 5 | 3 | 3 | 49 | 15 | 24 | 8 | 59 | 30 | 25 | 9 |
| Interest | 10 | 11 | 11 | 12 | 11 | 11 | 10 | 18 | 14 | 16 | 18 | 15 | 16 |
| Depreciation | 89 | 95 | 96 | 97 | 97 | 100 | 98 | 97 | 102 | 104 | 104 | 104 | 103 |
| PBT | -57 | -18 | -123 | -102 | -50 | -16 | -15 | 10 | -12 | 14 | 4 | 15 | 112 |
| Tax % | 0% | 0% | -6% | -55% | -11% | 15% | -27% | 13% | 15% | -21% | 621% | 3% | 51% |
| Net Profit | -57 | -18 | -115 | -46 | -45 | -18 | -11 | 9 | -14 | 16 | -20 | 15 | 55 |
| EPS in Rs | -7.78 | -2.5 | -15.68 | -6.29 | -6.06 | -2.48 | -1.53 | 1.2 | -1.88 | 2.23 | -2.72 | 2.04 | 7.49 |
Profit & Loss
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,995 | 2,070 | 2,455 | 3,161 | 2,725 | 2,429 | 3,759 | 4,516 | 3,807 | 4,073 | 4,358 | 4,498 |
| Expenses | 1,660 | 1,622 | 1,669 | 2,046 | 2,148 | 2,072 | 2,774 | 3,568 | 3,775 | 3,793 | 3,976 | 3,996 |
| Operating Profit | 335 | 448 | 786 | 1,115 | 577 | 357 | 984 | 949 | 32 | 279 | 382 | 501 |
| OPM % | 17% | 22% | 32% | 35% | 21% | 15% | 26% | 21% | 0.8% | 7% | 9% | 11% |
| Other Income | 45 | 56 | 106 | 62 | 90 | 67 | 46 | 42 | 90 | 92 | 117 | 124 |
| Interest | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 51 | 63 | 66 |
| Depreciation | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 | 414 | 416 |
| PBT | 262 | 381 | 749 | 1,016 | 491 | 235 | 826 | 695 | -300 | -71 | 21 | 144 |
| Tax % | 16% | 19% | 29% | 32% | 32% | 29% | 32% | 41% | -21% | -9% | 112% | — |
| Net Profit | 220 | 307 | 534 | 690 | 332 | 166 | 560 | 410 | -237 | -65 | -2 | 66 |
| EPS in Rs | 29.9 | 41.85 | 72.78 | 93.98 | 45.22 | 22.57 | 76.22 | 55.78 | -32.25 | -8.87 | -0.33 | 9.04 |
| Div. Payout % | 15% | 12% | 9% | 9% | 18% | 35% | 13% | 42% | -43% | -178% | -5394% | — |
Balance Sheet
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 |
| Reserves | 2,854 | 3,282 | 3,748 | 4,222 | 4,522 | 5,301 | 5,826 | 6,066 | 6,002 | 5,596 | 5,117 |
| Borrowings | 295 | 353 | 291 | 247 | 205 | 498 | 594 | 597 | 544 | 561 | 575 |
| Other Liabilities | 671 | 726 | 859 | 988 | 1,090 | 1,282 | 1,484 | 1,599 | 1,404 | 1,756 | 1,766 |
| Total Liabilities | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 | 7,533 |
| Fixed Assets | 1,821 | 2,073 | 2,104 | 2,300 | 2,610 | 2,587 | 2,702 | 4,250 | 4,617 | 4,584 | 4,343 |
| CWIP | 83 | 151 | 252 | 307 | 445 | 1,109 | 1,787 | 544 | 95 | 79 | 122 |
| Investments | 854 | 1,016 | 1,145 | 1,065 | 1,242 | 2,092 | 2,110 | 1,831 | 2,093 | 1,976 | 1,633 |
| Other Assets | 1,136 | 1,196 | 1,469 | 1,858 | 1,594 | 1,366 | 1,379 | 1,710 | 1,218 | 1,348 | 1,434 |
| Total Assets | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 | 7,533 |
Cash Flow
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 201 | 502 | 514 | 838 | 630 | 421 | 735 | 960 | 67 | 381 | 406 |
| Investing | -352 | -467 | -395 | -581 | -634 | -334 | -804 | -662 | -90 | -264 | -228 |
| Financing | 84 | 13 | -116 | -136 | -146 | 226 | 12 | -140 | -277 | -145 | -150 |
| Net Cash Flow | -67 | 49 | 3 | 122 | -150 | 313 | -58 | 158 | -301 | -28 | 28 |
| Free Cash Flow | -80 | 63 | 230 | 451 | 56 | -370 | -173 | 277 | -164 | 59 | 148 |
| CFO/OP | 75 | 132 | 83 | 98 | 121 | 133 | 106 | 121 | 353 | 112 | 100 |
Ratios
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 58 | 60 | 56 | 50 | 43 | 29 | 23 | 17 | 24 | 34 |
| Inventory Days | 99 | 94 | 147 | 99 | 92 | 88 | 101 | 111 | 93 | 110 | 102 |
| Days Payable | 99 | 125 | 154 | 134 | 126 | 111 | 101 | 119 | 86 | 115 | 111 |
| Cash Conversion Cycle | 60 | 27 | 53 | 22 | 17 | 21 | 29 | 15 | 25 | 19 | 25 |
| Working Capital Days | 89 | 81 | 98 | 96 | 107 | 10 | 4 | 5 | -1 | -3 | 1 |
| ROCE % | — | 11% | 18% | 24% | 11% | 5% | 13% | 11% | -4% | 0% | 1% |
Documents
1
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Aug - Intimation of Schedule of Analyst / Investor Meet to be held on 24.08.2026. Kindly refer attached file for more information. 18 Aug - Intimation of Schedule of Analyst / Investor Meet to be held on 24.08.2026. Kindly refer attached file for more information.
2
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
8 May - GACL filed annual large corporate disclosure for FY2025-26, reporting Rs 292.63 crore incremental borrowing. 8 May - GACL filed annual large corporate disclosure for FY2025-26, reporting Rs 292.63 crore incremental borrowing.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
24 Apr - Gujarat Alkalies confirms it is not a Large Corporate as of 31 March 2026; borrowing Rs. 367.635 crore. 24 Apr - Gujarat Alkalies confirms it is not a Large Corporate as of 31 March 2026; borrowing Rs. 367.635 crore.
4
Newspaper Advertisements.
18 Apr - Published ads on special window for transfer/dematerialisation of physical securities, open 05 Feb 2026 to 04 Feb 2027. 18 Apr - Published ads on special window for transfer/dematerialisation of physical securities, open 05 Feb 2026 to 04 Feb 2027.
5
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
12h - Gujarat Alkalies confirms it is not a Large Corporate as of 31 March 2026; borrowing Rs. 367.635 crore. 12h - Gujarat Alkalies confirms it is not a Large Corporate as of 31 March 2026; borrowing Rs. 367.635 crore.
Frequently Asked Questions about Gujarat Alkalies & Chemicals Ltd
What does Gujarat Alkalies & Chemicals Ltd do?
Incorporated in 1973, Gujarat Alkalies and Chemicals Ltd is promoted by the Government of Gujarat, with promoter-group shareholding of 47.28% as of FY26.
The company operates manufacturing complexes at Vadodara and Dahej, Gujarat, and has 50+ years of operating history in chlor-alkali and allied ...
Where is Gujarat Alkalies & Chemicals Ltd (GUJALKALI) listed?
Gujarat Alkalies & Chemicals Ltd is listed on the Indian stock exchanges. It is listed on NSE: GUJALKALI and BSE: 530001. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Gujarat Alkalies & Chemicals Ltd belong to?
Gujarat Alkalies & Chemicals Ltd operates in the Chemicals sector within the Commodity Chemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Gujarat Alkalies & Chemicals Ltd?
Gujarat Alkalies & Chemicals Ltd has a market capitalisation of approximately ₹4974.81 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Gujarat Alkalies & Chemicals Ltd?
The Price-to-Earnings (PE) ratio of Gujarat Alkalies & Chemicals Ltd is 75.06. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Gujarat Alkalies & Chemicals Ltd?
Over the past 52 weeks, Gujarat Alkalies & Chemicals Ltd has traded between a low of ₹409.15 and a high of ₹815. This range helps investors understand the stock's price volatility and recent trading levels.
Does Gujarat Alkalies & Chemicals Ltd pay dividends?
Yes, Gujarat Alkalies & Chemicals Ltd has a dividend yield of 2.60%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Gujarat Alkalies & Chemicals Ltd?
Gujarat Alkalies & Chemicals Ltd has a Return on Equity (ROE) of -1.15%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Gujarat Alkalies & Chemicals Ltd on Tapetide?
On Tapetide, you can view Gujarat Alkalies & Chemicals Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1973, Gujarat Alkalies and Chemicals Ltd is promoted by the Government of Gujarat, with promoter-group shareholding of 47.28% as of FY26. The company operates manufacturing complexes at Vadodara and Dahej, Gujarat, and has 50+ years of operating history in chlor-alkali and allied chemicals.[1]
Website gacl.com
CEO Mr. Shailesh Damani
Employees 1,388
Listed 1997-08-07
Face Value ₹ 10
Issued Size 7,34,45,242